Evidence map›Paper›PMID 24097249›Full record

ArticleCurrent infectious disease reports2013

Challenges in measuring antibiotic consumption.

Leigh Anne Hylton Gravatt, Amy L Pakyz

Abstract read
PubMed Publisher
In one paragraph

Article in Current infectious disease reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Prescribed daily-dose-based metrics of oral antibiotic use for hospitalized children in Japan.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Observational
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Leigh Anne Hylton GravattDepartment of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, 410 North 12th Street, P.O. Box 980533, Richmond, VA, 23298-0533, USA, lahyltongrav@vcu.edu.
Amy L Pakyz
Virginia Commonwealth University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The measurement of antibacterial consumption is important for tracking use over time, for assessing correlations between use and antibacterial resistance, and for serving as an outcome measure for antimicrobial stewardship programs. Accurate and consistent measures of use are important for meaningful inter- and intrainstitutional comparisons. The defined daily dose (DDD) and days of therapy methods are commonly used measures in the adult population; however, there is no one ideal measure of consumption that covers the breadth and depth of antibacterial prescribing. The use of the DDD and the prescribed daily dose methods, with further stratification of use by weight and age groups, aids in the evaluation of antimicrobial use in pediatric patients. Increasing availability of computerized pharmacy data should enhance the collection and analysis of data from hospitals.

Identifiers

PMID24097249
OpenAlexW2013470503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.